Internal Medicine Alert – September 15, 2004
September 15, 2004
View Issues
-
How Do You Rate Urate?
Elevated serum uric acid is a marker for cardiovascular mortality. -
Abdominal Aortic Aneurysm
Annual, or less frequent, surveillance intervals are effective for aneurysms < 45 mm in diameter. -
On-Demand Rabeprazole 10 mg Maintains Symptom Relief in Patients with Non-Erosive Reflux Disease
In patients with symptomatic nonerosive reflux disease, intermittent on-demand therapy with the PPI rabeprazole provided good symptom control with tablets taken on average approximately 1 day out of 4. -
We Can Improve the Treatment of Patients with Atrial Fibrillation
Angiotensin-converting enzyme inhibitors decreased the number of defibrillation attempts needed and reduced hospitalization in patients with atrial fibrillation. -
Pharmacology Update: Ezetimibe and Simvastatin Tablets (Vytorin)
The FDA has approved the combination of ezetimibe and simvastatin for the treatment of hypercholesterolemia. This combination product provides different mechanisms of action for lowering cholesterol. -
Clinical Briefs
The Dietary Approaches to Stop Hypertension diet, which suggests high intake of fruits, vegetables, and low-fat diary products, has been shown to favorably affect blood pressure in Stage 1 Hypertension as well as pre-hypertension. -
ECG Review: Healthy Patient/Many Findings
12-lead ECG obtained from a healthy, asymptomatic 42-year-old man. How many findings can you identify? -
Pharmacology Watch: New Clinical Guidelines on Cholesterol Management
The National Cholesterol Education Program, a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.